Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery
Clinical trial NCT02097732 · TERMINATED
Trial details
- NCT number
- NCT02097732
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2016-08-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.